Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 211 AL 225

Effect of genotype and age on cerebral [(18)F]FDG uptake varies between transgenic APP(Swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease

Snellman A, Takkinen JS, López-Picón FR, Eskola O, Solin O, Rinne JO, Haaparanta-Solin M.

Sci Rep. 2019 Apr 5;9(1):5700. doi: 10.1038/s41598-019-42074-4.

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

Dionisio-Santos DA, Olschowka JA, O'Banion MK.

J Neuroinflammation. 2019 Apr 5;16(1):74. doi: 10.1186/s12974-019-1453-0.

Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease

Ozben T, Ozben S.

Clin Biochem. 2019 Oct;72:87-89. doi: 10.1016/j.clinbiochem.2019.04.001. Epub 2019 Apr 4.

Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer's Disease

Guo H, Zhao Z, Zhang R, Chen P, Zhang X, Cheng F, Gou X.

J Alzheimers Dis. 2019;68(4):1391-1400. doi: 10.3233/JAD-181177.

A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio

Qiu Q, Shen L, Jia L, Wang Q, Li F, Li Y, Jia J.

J Alzheimers Dis. 2019;69(1):199-212. doi: 10.3233/JAD-181291.

Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?

De Simone A, Milelli A.

ChemMedChem. 2019 Jun 5;14(11):1067-1073. doi: 10.1002/cmdc.201900174. Epub 2019 May 2.

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy

Tosi G, Pederzoli F, Belletti D, Vandelli MA, Forni F, Duskey JT, Ruozi B.

Prog Brain Res. 2019;245:57-88. doi: 10.1016/bs.pbr.2019.03.001. Epub 2019 Apr 2.

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age

Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS.

Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z.

Dystonin/BPAG1 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis

Cheng J, Liu HP, Hwang SL, Hsu LF, Lin WY, Tsai FJ.

Neurol Sci. 2019 Aug;40(8):1577-1582. doi: 10.1007/s10072-019-03879-3. Epub 2019 Apr 8.

Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease

Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA.

Curr Alzheimer Res. 2019;16(10):871-894. doi: 10.2174/1570159X17666190409144558.

Formaldehyde, Epigenetics, and Alzheimer's Disease

Wang F, Chen D, Wu P, Klein C, Jin C.

Chem Res Toxicol. 2019 May 20;32(5):820-830. doi: 10.1021/acs.chemrestox.9b00090. Epub 2019 Apr 19.

Molecular Targets in Alzheimer's Disease

Bjørklund G, Aaseth J, Dadar M, Chirumbolo S.

Mol Neurobiol. 2019 Oct;56(10):7032-7044. doi: 10.1007/s12035-019-1563-9. Epub 2019 Apr 9.

Lowering of Amyloid-Beta by β-Secretase Inhibitors - Some Informative Failures

Knopman DS.

N Engl J Med. 2019 Apr 11;380(15):1476-1478. doi: 10.1056/NEJMe1903193.

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH.

Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11.

On the central role of mitochondria dysfunction and oxidative stress in Alzheimer's disease

Tobore TO.

Neurol Sci. 2019 Aug;40(8):1527-1540. doi: 10.1007/s10072-019-03863-x. Epub 2019 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias